Introduction
The antigenic structure of the tobacco mosaic virus (TMV) coat protein (CP) has been studied extensively (van Regenmortel, 1981 (van Regenmortel, , 1999 . Various serological techniques including precipitation, complement fixation, haemagglutination and ELISA have been used to identify epitopes recognized by monoclonal antibodies (MAbs). Studies using synthetic peptides indicate that almost the entire sequence of the TMV CP is antigenic and that the CP contains more than 13 continuous epitopes (Al Moudallal et al., 1982 ; Dore et al., 1987) . The majority of the epitopes are composed of fewer than ten amino acid residues and correspond to regions found in CP surface projections, such as loops and turns Dore et al., 1988) . On the basis of these findings, and in order to evaluate the source of the biological effects of transgenically expressed MAbs in Nicotiana tabacum (Tavladoraki et al., 1993) , the TMV CP was used to generate a panel of MAbs. One of these was the high-affinity MAb29 (K d 1i10 −* ), generated by standard hybridoma technology using TMV vulgare CP as the antigen. Since the recombinant full-size antibody rAb29 and its derivative scFv29 can be functionally expressed in N. tabacum , we were Author for correspondence : Rainer Fischer (at RWTH Aachen).
Fax j49 241 871062. e-mail fischer!bio1.rwth-aachen.de interested in mapping the CP epitope recognized by MAb29 and its derivatives. Detailed knowledge of the epitope would help to elucidate structure-function relationships in vivo by using rAb29-or scFv29-expressing plants.
Current epitope-mapping techniques are based on the scanning of solid-phase peptide libraries or screening of random peptide libraries displayed on the filamentous bacteriophage pIII and pVIII surface proteins (Lane & Stephen, 1993 ; Smith, 1991) . Display of linear or constrained random peptide sequences on filamentous bacteriophages has led to the identification of many epitopes recognized by MAbs (Sibille & Strosberg, 1997 ; Stephen et al., 1995) and has become an important technique for the evaluation of protein-protein interactions (Burritt et al., 1996) . However, these epitopemapping methods are tedious and have certain limitations. In random peptide library panning, selection is based on the affinity between the antibody and the library peptides, most of which do not share sequence similarity with the antigen. This can lead to identification of peptides that have high affinity but only little sequence similarity to the original protein (' mimotopes ') (Bo$ ttger et al., 1995) . As a result, high-affinity antibodybinding peptides identified from random combinatorial libraries may not be useful for identifying the recognized epitope within the antigen. A second limitation of random peptide display in identifying actual epitopes is the time required to enrich specific phage clones. Typically, three or more rounds of panning are needed to derive a consensus amino acid sequence and to deduce the epitope. This is costly and labour intensive, typically requiring 3 to 4 weeks. Additionally, a random peptide library, despite a theoretical size of 10"# peptides, may not include all possible amino acid combinations and therefore may not contain specific binding-peptide motifs.
Displaying gene fragments of the antigen on phage is a promising alternative for rapid identification of the actual epitopes recognized by antibodies. This approach has the advantage that antigen-derived peptides are affinity-selected by the corresponding MAb and these peptides are subsequently used to identify the epitope. Additionally, the number of non-specific peptides included in a gene-fragment library is much smaller compared with random peptide libraries. These advantages can permit the identification of epitope motifs after only one round of affinity selection with the respective MAb. Most gene-fragment libraries displayed on bacteriophage described to date have been based on fusion to the gene III protein (Fack et al., 1997 ; Gupta et al., 1999 ; Jacobsson & Frykberg, 1995 ; Jacobsson et al., 1997) , which is present in only three to five copies per phage. In contrast, the bacteriophage gene VIII protein is present at " 2700 copies per phage particle and has also been used successfully to display random peptide libraries on a phage surface (Felici et al., 1991) . Peptide display using the filamentous bacteriophage gene VIII product (Jacobsson & Frykberg, 1996) also increases the number of displayed peptides to up to 1000 copies per phage particle (Cesareni, 1992) .
In this study, the feasibility of panning a gene-fragment library displaying short sequence motifs derived from the TMV CP as pVIII-peptide fusions on filamentous phage was investigated. Our rationale was to develop a method for the rapid identification of the TMV CP epitope recognized by MAb29 that could subsequently be used for determination of other epitopes recognized by TMV CP-specific MAbs. Identification of the MAb29 epitope would also help to define MAb specificity amongst different tobamovirus strains and could be used to confirm binding data obtained from standard ELISA with this antibody. Furthermore, an approach is discussed whereby gene-fragment libraries are used for evaluation of MAb epitopes, in comparison with established epitopemapping technologies such as peptide scanning.
Methods
Production and purification of MAbs. Immunization, fusion and hybridoma generation were performed according to standard protocols (Coligan et al., 2000) with 100 µg TMV vulgare CP per boost as antigen. The serum titre from immunized mice was determined by ELISA. Only mice showing a TMV CP-specific antibody titre greater than 1 : 500 000 were subsequently used for generation of hybridoma clones. The fusion of myeloma and spleen cells was done as described previously (Westerwoudt, 1985) . After two limiting-dilution cloning steps, ELISApositive clones were expanded from 96-well microculture plates (Nunc) into suspension mass cultures. The determination of TMV CP-specific MAb production, reactivity, affinity, isotype and specificity was performed as described previously (Ha$ mmerling & Ha$ mmerling, 1981) . MAb29, an IgG " \kappa isotype, was purified from the culture supernatant by affinity chromatography on Prosep-A HC (Bioprocessing). The purity of the MAb29 preparation was confirmed by SDS-PAGE and silver staining.
Construction of the TMV CP gene-fragment library in pC89. All standard molecular biology techniques used in this study were performed according to standard protocols (Ausubel et al., 2000) . Peptide display techniques were performed as described previously (Felici et al., 1991) . The phagemid pC89 (Felici et al., 1991) was isolated from a clone of a linear 9-mer peptide display library (pVIII 9aa), which was kindly provided by R. Cortese (IRBM, Rome ; Fig. 1 ). The TMV-RT vector (Verch et al., 1998 ) is a pUC18-based plasmid containing the complete TMV genome and was used to amplify the TMV CP gene by PCR prior to subsequent DNase I fragmentation. The plasmid pGEX-5x-3 (Pharmacia) was used to clone a glutathione S-transferase (GST)-fusion peptide containing the determined TMV CP epitope of MAb29 and a MAb29-non-reactive TMV CP domain as a negative control. E. coli strain TG1 (Stratagene) was used for the construction of the TMV CP gene-fragment library. E. coli strain BL21 (Stratagene) was used to express GST-fusion peptides. The TMV CP gene was amplified by PCR from the TMV-RT vector by using the following oligonucleotides : CP3, 5h CCGTCAGAC-GTCAGAACCTCCACCTCCACTTCCGCCGCCTCCAGTTGCA-GGACCAGAGGTCCAAACCAAACC 3h ; and CP5, 5h ACTGCGCCA-TGGCTTACAGTATCACT 3h. DNase I fragmentation of the PCR product was carried out as described previously (Anderson, 1981) by using 90 µg of the PCR product, generating DNA fragments of " 25-150 bp. DNA fragments were blunt-ended with T4 DNA polymerase, separated on a 5 % (w\v) polyacrylamide gel and then recovered from the gel. The phagemid pC89 ( Fig. 1 ) was digested with EcoRI and BamHI, blunt ends were generated by T4 DNA polymerase treatment and the vector was dephosphorylated with shrimp alkaline phosphatase (AP). The ligation reaction contained 75 ng gel-purified TMV CP genefragment DNA and 20 ng vector DNA and was used to transform E. coli TG1 by electroporation. Recombinant phages were collected upon M13KO7 helper phage (Life Technologies) infection (Vieira & Messing, 1987) and PEG6000 precipitation. The transforming unit (TU) titre of the library was determined as described previously (Vieira & Messing, 1987) .
Panning of the gene-fragment library. Biopanning of the genefragment library was conducted according to Fack et al. (1997) with 20 µg affinity-purified MAb29. For the first round of panning, 5i10"# TU in 1 ml PBSj was used and bound phage was eluted with 1 ml glycine-HCl, pH 2n2, 0n1% (w\v) BSA (10 min, 20 mC). The titre of eluted phage was determined by plating 100 µl of the infected bacteria on 2iTY-Amp plates and counting the colony forming units (c.f.u.). Enrichment factors were calculated by comparison with a control panning of the TMV CP library screened without MAb29. Monoclonal phages from the first round of panning were tested for reactivity with MAb29 by phage-ELISA (Valadon & Scharff, 1996) with 100 ng of TMV CP coated to each well of the ELISA plate. Antibody-bound phages were detected with an anti-M13 antibody-horseradish peroxidase conjugate (Pharmacia) followed by incubation with 100 µl of 1 mg\ml ABTS [2,2h-azinobis(3-ethylbenzthiazoline-6-sulphonic acid)] in ABTS buffer (Roche Diagnostics). A %!& values were determined after incubation with substrate for 60 min and were measured by using a SpectraMax 340 spectrophotometer (Molecular Devices).
Cloning, expression and competition ELISA using GSTfusion proteins. Two regions of the TMV CP, one containing aa 53-75 as a negative control and one containing aa 126-139, which is the epitope recognized by MAb29 as identified by peptide display, were cloned as C-terminal fusions to GST. The nucleotide sequences for each peptide, a Gly % -Ser linker and an NcoI restriction site were fused by PCR to the C terminus of the GST gene by using pGEX-5x-3 (Pharmacia) as template. Primer length was minimized by using two nested backward primers for each reaction : pr126TMV1 (5h TTTCTCGAGGATCAGG-TTGTTTCCATGGGAACCACCACCACCCTGGATCCCACGACC-TTCGAT 3h) and pr126TMV2 (5h TTTCTCGAGTCAGTAGGAA-CCGGTACCACGGATCAGTTCAACGATCAGGTTGTTTCCATG-GGA 3h) for GST-126 and pr157TMV1 (5h AAACTCGAGACG-GTAACTTGCGGGGACGGTTTCCATCCATGGGAACCACCACC-ACCCTGGATCCCACGACCTTCGAT 3h) and pr157TMV2 (5h AAACTCGAGTCAAGCGTTGTAACGGTAAACTTTGAAGTCG-GAGTCCGGGAAACGAACGGTAACTTGCGGGGACGGT 3h) for GST-157 in combination with the common forward primer GST-BspM1 (5h CATCGGAAGCTGTGGTATGG 3h). After cloning the GST-126 and GST-157 fusion proteins, the correct product was verified by DNA sequencing of plasmid DNA obtained from recombinant bacteria. Upon expression in E. coli BL21 and affinity purification on glutathioneSepharose 4B columns (Pharmacia), the yield and purity of the recombinant GST-fusion proteins were determined by SDS-PAGE.
Competition ELISA was carried out as described with 1 µg\ml GST-126 in PBS per well. Serial dilutions ranging from 5n47 µM to 0n03 nM of GST-126 and TMV CP were prepared in PBS, pH 9n0. MAb29 was added to a final concentration of 1n25 nM. Competition of soluble GST-126 or TMV CP against immobilized GST-126 for binding to MAb29 was carried out for 2 h at 22 mC. Bound MAb29 was detected with an APconjugated goat anti-mouse antibody (Dianova) followed by incubation with 100 µl of 1 mg\ml AP substrate (Sigma). A %!& values were measured 60 min after substrate addition by using a SpectraMax 340 spectrophotometer (Molecular Devices). Intermediate washing steps were carried out three times with PBST. IC &! values were derived by fitting the data to the equation R l A bg j(A max kA bg )\(1jA sample \IC &! ) (where A bg is the background, A max the reactivity of MAb29 without competitor and A sample the reactivity of MAb29 in the samples ; R is the reactivity of the sample and IC &! represents the dilution at which the reactivity of MAb29 is reduced to 50 %) by using Microcal Origin 5.0.
DNA sequencing. Plasmid DNA from ELISA-positive clones was isolated from recombinant E. coli DH5α or TG1 cultures by using the Qiagen Mini Spinprep kit and sequenced by using specific primers in combination with the Thermo-sequenase fluorescence-labelled primer cycle sequencing kit (Amersham-Pharmacia). Sequencing reactions were run on a LiCor-4200L DNA sequencer (MWG-Biotech). Sequences were analysed using the Wisconsin package (GCG, Madison, WI, USA).
Results
The gene-fragment phage display library was constructed by ligating blunt-ended DNA fragments of the TMV CP gene into the blunt-ended EcoRI\BamHI-restricted phagemid pC89 (Fig. 1) . The TMV CP sequence was amplified by PCR from the TMV-RT vector, which contains a full-length infectious cDNA clone of TMV. After separation by PAGE, " 25-150 bp DNase I fragments of the 527 bp TMV CP PCR product were ligated into the phagemid pC89. This resulted in the surface display of a library presenting 8-50 amino acid long peptides of the TMV CP gene fused to pVIII.
The TMV CP gene-fragment library consisted of " 6i10% primary transformants, resulting in 5i10"% TU after overnight amplification of phage in a 200 ml E. coli TG1 culture. Only clones that are in-frame at both junctions (signal peptide\gene fragment and gene fragment\pVIII) and show the correct orientation will display peptide fragments corresponding to the original TMV CP amino acid sequence. This represents a statistical maximum of 5n5 % of the primary transformants being capable of displaying TMV CP-derived peptides.
Approximately 5i10"# TU were used for the first round of panning with 20 µg MAb29 immobilized on the solid phase. In the first round of panning, 1n1i10' TU were eluted, which corresponds to a 35-fold enrichment compared with a control panning of the TMV CP-gene VIII library without MAb29. More than 80 % of the monoclonal phages amplified after the first round of panning showed strong specific signals (A %!& 0n5) in phage ELISA, using MAb29 as the capturing antibody (Fig. 2 a, b) .
Sequencing of phagemid DNA from ten randomly chosen ELISA-positive clones from the first round of panning revealed eight highly similar and overlapping inserts. The insert sizes varied from 24 bp (8 amino acids) to 114 bp (38 amino acids) and a common region of seven amino acids was deduced (Fig. ( 3). This seven amino acid sequence corresponded exactly to amino acid residues 131-137 ("$"ELIRGTG"$() of the TMV CP sequence. A single clone contained two fragments of the TMV CP sequence. The first contained the seven amino acid epitope, but the second fragment of the TMV CP gene was inversely inserted, so that amino acid residues not available in the TMV CP were displayed (Fig. 3, clone 31) .
Based on the highly specific ELISA signals and the high degree of similarity between the sequenced clones, a consensus sequence (amino acid residues ELIRGTG) was deduced as the actual linear epitope recognized by MAb29. Amino acids that flanked the common seven amino acids were not conserved in all ten clones analysed. Amino acid residues V"$! and S"$)-N"%! were not necessary for MAb29 binding. Although present in nine of ten clones each, ELISA-positive clones were identified that were missing at least one of these amino acids (Fig. 3 , clones 21 and 44). In order to verify the results obtained by screening the gene-fragment library, two regions of the TMV CP were cloned as C-terminal fusions to GST by using the pGEX expression system : GST-126 (Fig. 4 a) , covering the MAb29 epitope identified by panning the gene-fragment library with MAb29, and GST-157 (Fig. 4 a) , covering amino acids 53-75, which form an immunodominant loop structure on the native TMV CP. After expression of both sequences in E. coli BL21 and subsequent purification by GST-affinity chromatography of the recombinant proteins, strong reactivity of MAb29 against GST-126 was observed in ELISA and in Western blotting, while no reactivity was detected with GST-157 or native GST (data not shown). Furthermore, a competition ELISA was carried out, which revealed that soluble GST-126 was a better competitor for binding of MAb29 to GST-126 (Fig. 4 b) or TMV CP (data not shown) than soluble TMV CP. With soluble TMV CP, 50 % of the colorimetric reaction was inhibited at a concentration of 918 nM (IC &! ). In contrast, GST-126 was at least 25-fold more active and inhibited 50 % of the MAb29 reactivity at 33n6 nM.
Discussion
The construction of the gene-fragment library was straightforward. The cloning procedure utilized blunt-end ligations and did not require any adapters or linkers. The epitope recognized by MAb29 was determined rapidly in a single round of panning of the TMV CP gene-fragment library (Fig.  2) . By aligning the deduced amino acid residues of the eight different inserts (Fig. 3) , a common region of seven amino acids in the TMV CP sequence ("$"ELIRGTG"$() was identified as the epitope recognized by MAb29. This was confirmed by expression and binding-assay evaluation of the identified epitope as a C-terminal fusion to GST (GST-126 ; Fig. 4 a) . Competition ELISA revealed a more than 25-fold higher IC &! for TMV CP compared with GST-126. This might be due to the strong tendency of TMV CP to aggregate and to form trimers or polymeric discs (Bloomer & Butler, 1986) , even under competition ELISA conditions (pH 9). Inspection of the 3D structure of TMV CP indicated that aggregation leads to inaccessibility of the epitope recognized by MAb29. This also agrees with the observation that MAb29 does not react with intact virions. GST-126 presents the epitope as a C-terminal fusion tail, which is very accessible for MAb29. This makes GST-126 suitable for affinity purification of MAb29 and its derivatives (Fischer et al., 1999) .
The time taken for the identification of the MAb29 epitope and the cost incurred were low compared with other techniques suitable for epitope mapping, such as the screening of random peptide display phage libraries (Scott & Smith, 1990) or synthetic peptide scanning analysis (PEPSCAN) (Geysen et al., 1984) . Furthermore, the libraries generated can be reused, thus enabling the cost-effective screening of a panel of MAbs that have been raised against the same antigen. The primary advantage of epitope mapping by gene-fragment libraries compared with random peptide libraries is that the content of specific target peptides is initially much higher. By cloning the library by using a cDNA encoding the antigen, a sufficient diversity can be several orders of magnitude smaller compared with a random peptide library and one single round of panning still results in epitope identification. The TMV CP genefragment library used in this study consisted of " 6i10% primary transformants, of which 3n3i10$ (5n5 %) displayed inserts in the correct reading frame. With an average peptide size of " 25 amino acids, this easily covered the 159 amino acids of the TMV CP with overlapping inserts. This is also demonstrated by the fact that one round of panning resulted in 80 % MAb29-reactive clones, from which ten randomly chosen clones had eight different gene fragments inserted, but all contained the seven amino acid epitope, as deduced by sequencing. Considering these results, it even seems possible to adopt an epitope-mapping approach whereby any kind of biopanning is avoided, simply by identifying epitope-bearing clones from the initial gene-fragment library by phage ELISA.
While display of peptides on pIII of filamentous phage gives one to three recombinant copies per phage particle, the fusion of gene fragments to gene VIII results in the display of recombinant peptides at up to " 1000 copies per phage (Cesareni, 1992) , thus covering the entire phage with a large number of identical peptides. This increases the efficiency of the panning process compared with pIII libraries for peptide display and enables a more efficient enrichment of phages, as long as the displayed peptide does not interfere with bacteriophage assembly. The use of the target gene for setting up the library permitted rapid identification of the actual linear epitope recognized by MAb29, as shown by sequence comparison with the TMV CP sequence. Panning of random peptide libraries often leads to the identification of so-called ' mimotopes ', which are specific binding peptides with little or no sequence similarity to the original target sequence, but which adopt a 3D structure that resembles the epitope and are recognized by the MAb. Since these mimotopes cannot be used to define the actual epitope, screening of random peptide libraries has limitations for mapping actual epitopes recognized within the antigen sequence. Moreover, panning random peptide libraries with MAbs can result in only a few independent specific clones with low sequence similarity (Bo$ ttger et al., 1995) .
Gene-fragment libraries have been successfully used for the mapping of epitopes where other epitope-mapping techniques have failed (Fack et al., 1997) . For the construction of the TMV CP gene-fragment library, we chose a peptide length of 8-50 amino acids, which increases the likelihood that a longer epitope or an epitope adopting a particular structural conformation will be recognized by the MAb. The screening of fully synthetic libraries by PEPSCAN analysis (Geysen et al., 1984) can be labour-and time-intensive and requires expensive materials or special equipment. In PEPSCAN analysis, the complete antigen sequence is represented by overlapping synthetic peptides of 6-15 amino acids. Screening for reactivity is usually performed by ELISA or dot blotting. Identification of specific peptides in this way depends strongly on the size of the recognized epitope and can be influenced by the solubility of the synthetic peptides. It has been reported that conformational or large linear epitopes are unlikely to be identified by this technique (Fack et al., 1997) .
A limitation of gene-fragment display as discussed here is that only linear epitopes are likely to be identified. The mapping of conformational epitopes is not usually possible, although variation of the gene-fragment insert length might narrow the epitope to certain regions or distinct protein domains. It has been observed that, whenever a MAb is capable of recognizing its antigen in Western blotting, it also selects specific clones from gene-fragment display libraries of the target protein (Fack et al., 1997) . For the identification of mimotopes, thus mimicking a conformational epitope with a linear peptide, the screening of disulphide bond-constrained random peptide libraries is a more promising alternative (Cortese et al., 1995 ; Lane & Stephen, 1993 ; Luzzago et al., 1993) , although this will rarely lead to the identification of the actual epitope sequence.
The screening of gene-fragment libraries as described here is a rapid, reliable and convenient technique for the identification of actual, linear epitopes recognized by sets of MAbs raised against the same antigen. It is highly efficient, less timeconsuming and less expensive when compared with other methods and does not involve expensive or dedicated material or equipment. Due to the possibility of mapping back the identified binding sequence to the sequence of the antigen, this technique is particularly useful in the process of evaluating MAbs that bind to conserved epitopes as deduced from sequence comparisons. In the case of the TMV CP, which has been isolated from many strains that differ mainly in their CP sequence (van Regenmortel, 1981) , this may lead to the identification of conserved CP motifs that can be used for subsequent studies .
